2015-06-29 18:29:17 UTC

Beyder Receives 2015 AGA Research Scholar Award

June 29, 2015

Arthur Beyder, MD, PhD, hopes to improve our understanding of the molecular mechanisms of EC cell operation for future IBS treatment.

Arthur Beyder, MD, PhD, from Mayo Clinic, Rochester, MN, is a recipient of the 2015 AGA Research Scholar Award. Dr. Beyder, an aspiring academic gastroenterologist, will use this research funding to improve our understanding of functional GI disorders, specifically IBS.   

While the diagnosis of IBS is made clinically by episodic abdominal pain and disordered defecation, the pathophysiologic details of this multisystem disorder are much more complex. Studies have shown that the enterochromaffin (EC) cells within the luminal GI tract are involved in the pathogenesis of IBS. Dr. Beyder’s goal is to determine the molecular mechanisms of EC cell operation, specifically focusing on EC cell mechanosensation.

Thanks to this grant from the AGA Research Foundation, which will protect his time for research, Dr. Beyder will work to improve our understanding of the molecular mechanisms of EC cell operation in health and disease and use this knowledge to develop novel diagnostic and therapeutic options for patients with functional GI disorders. 

Dr. Beyder is grateful to the selection committee for recognizing his work and would like to thank the AGA Research Foundation and foundation donors for their generous support.

More on Constipation

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

The Lowdown on the Low-FODMAP Diet

Nov. 1, 2017

As the low-FODMAP diet grows in popularity, know the facts to help answer patient questions and provide guidance.

A Man With Intermittent Abdominal Pain, Liver Injury, and Renal Impairment

Aug. 24, 2017

A 45-year-old man presented with intermittent abdominal pain, dark urine, and constipation for 6 months.